PMID: 42294355

Comparative Effectiveness and Safety of Once-Weekly Injectable Semaglutide Versus Dulaglutide in Individuals with Type 2 Diabetes Managed in UK Primary Care: A Population-Based Cohort Study.

Ulrich Franziska S, Frost Nielsen Morten, Napoli Nicola, Burden Andrea M

The Lancet regional health. Europe · 2026

Vol. 67, pp. 101738

View on PubMedDOI

This entry links to third-party literature. For research use only.

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.